S

Sacramento Eye Consultants | Sacramento, CA

Research site

(Unclaimed)

Location

1515 Response Road, Sacramento, California, United States of America

Site insights

Top conditions

Top treatments

Timolol Maleate

Ripasudil

DE-126

KPI-121

PVP

AGN-193408

Bimatoprost

Iodine

AGN-190584

DE-117

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 12 total trials

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.

Enrolling

Fuchs Endothelial Corneal Dystrophy

Drug: Ripasudil

Drug: Placebo

A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

A study to assess the safety and efficacy of K-321 in participants with FECD after simultaneous cataract surgery and descemetorhexis.

Active, not recruiting

Fuchs Endothelial Corneal Dystrophy

Drug: Placebo

Drug: Ripasudil

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Enrolling

Open-angle Glaucoma

Ocular Hypertension

Other: Sham Administration

Drug: AGN-193408 SR

Hydrus® Microstent New Enrollment Post-Approval Study (CONFIRM)

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24...

Enrolling

Primary Open Angle Glaucoma

Device: Hydrus Microstent

Device: Monofocal IOL

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (Maia)

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hyper...

Invitation-only

Open-Angle Glaucoma

Ocular Hypertension

Drug: Bimatoprost SR

Other: Standard of Care